A carregar...
Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?
Lung cancer remains the most significant contributor of cancer-related mortality globally. Despite the significant progress over the last decade with the introduction of targeted and immunotherapeutic agents in the treatment of advanced non-small cell lung cancer (NSCLC), chemotherapy is still the a...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952027/ https://ncbi.nlm.nih.gov/pubmed/29862228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.04.04 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|